[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336058-105":59,"doc-detail-336058-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","linc00115-promotes-chemoresistant-breast-cancer-stem-like-cell-stemness-and-metastasis-through-setdb1plk3hif1-signaling-research-open-access","LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling - Research Open Access","","The study investigates how LINC00115 drives chemoresistance, stemness, and metastasis in breast cancer stem-like cells. Using genome-wide lncRNA profiling, it identifies LINC00115 as strongly upregulated in paclitaxel-resistant ALDH+ BCSCs. Mechanistic experiments—including RNA pull-down, RIP, RNA sequencing, mass spectrometry, and CRISPR/Cas9 knockout—show LINC00115 scaffolds SETDB1 and PLK3, promoting PLK3 methylation and increasing HIF1α stability, which in turn elevates ALKBH5 to remodel LINC00115 m6A and sustain RNA stability. Targeting LINC00115 or SETDB1 improves therapeutic response in xenograft models and links pathway components to prognosis in triple-negative breast cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/linc00115-promotes-chemoresistant-breast-cancer-stem-like-cell-stemness-and-metastasis-through-setdb1plk3hif1-signaling-research-open-access/336058/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/linc00115-promotes-chemoresistant-breast-cancer-stem-like-cell-stemness-and-metastasis-through-setdb1plk3hif1-signaling-research-open-access/336058.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main discovery about LINC00115 in chemoresistant breast cancer stem-like cells?","Question",{"text":112,"@type":113},"LINC00115 is robustly upregulated in chemoresistant breast cancer stem-like cells and acts as a scaffold lncRNA that links SETDB1 and PLK3, promoting a signaling cascade that enhances stemness, chemoresistance, and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the SETDB1/PLK3/HIF1α pathway connect to increased LINC00115 stability?",{"text":117,"@type":113},"SETDB1 methylates PLK3, which reduces PLK3 phosphorylation of HIF1α and increases HIF1α stability. HIF1α then upregulates ALKBH5, reducing m6A modification of LINC00115 and attenuating YTHDF2-dependent degradation, thereby increasing LINC00115 stability.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports therapeutic targeting of LINC00115 or SETDB1?",{"text":121,"@type":113},"The therapeutic potential is assessed using gain- and loss-of-function studies and xenograft animal models, where a SETDB1 inhibitor (TTD-IN) combined with LINC00115 ASO sensitizes PTX-resistant cell responses to chemotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336058,1790189348,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":81,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Luo etal. Molecular Cancer (2024) 23:60 Molecular Cancer  \n[https://doi.org/10.1186/s12943-024-01975-3](https://doi.org/10.1186/s12943-024-01975-3)  \nRESEARCH Open Access  \nLINC00115 promotes chemoresistant breast  cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling  \nFei Luo 1†, Mingda Zhang 1†, Bowen Sun 1†, Chenxin Xu 1, Yi Yang2, Yingwen Zhang 1, Shanshan Li2, Guoyu Chen 1, Ceshi Chen3*, Yanxin Li2* and Haizhong Feng 1*  \nAbstract  \nBackground Cancer stem-like cel l is a key barrier for therapeutic resistance and metastasis in various cancers, including breast cancer, yet the underlying mechanisms are still elusive. Through a genome-wide lncRNA expression profiling, we identified that LINC00115 is robustly upregulated in chemoresistant breast cancer stem-like cells (BCSCs) . Methods LncRNA microarray assay was performed to document abundance changes of lncRNAs in paclitaxel (PTX)-resistant MDA-MB-231 BCSC (ALDH+) and non-BCSC (ALDH − ) . RNA pull-down and RNA immunoprecipitation (RIP) assays were performed to determine the binding proteins of LINC00115 . The clinical significance of the LINC00115 pathway was examined inTNBC metastatic lymph node tissues. The biological function of LINC00115 was investigated through gain-and loss-of-function studies. The molecular mechanism was explored through RNA sequencing, mass spectrometry, and the CRISPR/Cas9-knockout system. The therapeutic potential of LINC00115 was examined through xenograft animal models.  \nResults LINC00115 functions as a scaffold lncRNA to link SETDB1 and PLK3, leading to enhanced SETDB1 methylation of PLK3 at both K106 and K200 in drug-resistant BCSC. PLK3 methylation decreases PLK3 phosphorylation of HIF1α and thereby increases HIF1α stability. HIF1α, in turn, upregulates ALKBH5 to reduce m6A modification of LINC00115, resulting in attenuated degradation of YTHDF2-dependent m6A-modified RNA and enhanced LINC00115 stability. Thus, this positive feedback loop provokes BCSC phenotypes and enhances chemoresistance and metastasis in triple-negative breast cancer. SETDB1 inhibitor TTD-IN with LINC00115 ASO sensitizes PTX-resistant cell response to chemotherapy in a xenograft animal model. Correlative expression of LINC00115, methylation PLK3, SETDB1, and HIF1α are prognostic for clinical triple-negative breast cancers.  \n†Fei Luo, Mingda Zhang and Bowen Sun contributed equally to this work.  \n*Correspondence:  \nCeshi Chen[chenc@kmmu.edu.cn](chenc@kmmu.edu.cn)[ ](chenc@kmmu.edu.cn)Yanxin Li[liyanxincau@163.com](liyanxincau@163.com)[ ](liyanxincau@163.com)Haizhong Feng [fenghaizhong@sjtu.edu.cn](fenghaizhong@sjtu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nLuo et al. Molecular Cancer (2024) 23:60 Page 2 of 21  \nConclusions Our findings uncover LINC0011","cbCaintR0U87evj6","https://ap.wps.com/l/cbCaintR0U87evj6","pdf",12501210,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Cancer stem-like cells and therapy resistance\n## Roles of long non-coding RNAs in cancer\n## LINC00115 in multiple cancer types\n## HIF1α pathways in breast cancer","[{\"question\":\"What is the main discovery about LINC00115 in chemoresistant breast cancer stem-like cells?\",\"answer\":\"LINC00115 is robustly upregulated in chemoresistant breast cancer stem-like cells and acts as a scaffold lncRNA that links SETDB1 and PLK3, promoting a signaling cascade that enhances stemness, chemoresistance, and metastasis.\"},{\"question\":\"How does the SETDB1/PLK3/HIF1α pathway connect to increased LINC00115 stability?\",\"answer\":\"SETDB1 methylates PLK3, which reduces PLK3 phosphorylation of HIF1α and increases HIF1α stability. HIF1α then upregulates ALKBH5, reducing m6A modification of LINC00115 and attenuating YTHDF2-dependent degradation, thereby increasing LINC00115 stability.\"},{\"question\":\"What evidence supports therapeutic targeting of LINC00115 or SETDB1?\",\"answer\":\"The therapeutic potential is assessed using gain- and loss-of-function studies and xenograft animal models, where a SETDB1 inhibitor (TTD-IN) combined with LINC00115 ASO sensitizes PTX-resistant cell responses to chemotherapy.\"}]","LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling - Research Open Access | PDF",1790013417,53,[147,151,155],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/2c31be3493ccd720290e9a446c75ef78.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/184ab4594214cded9592a0b543deabf7.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/41918f05ea22565e23be2c58d27a5812.webp",981,1308]